Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

Journal of Hypertension

Volumn 19, Issue 5, 2001, Pages 921-930

  Park, Jeong Bae ^a,b   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Blood pressure; Cardiac hypertrophy; Endothelial dysfunction; Endothelium; Remodeling; Resistance arteries

Indexed keywords

ACETYLCHOLINE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIUM LESION; ESSENTIAL HYPERTENSION; FEMALE; HEART; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN TISSUE; MALE; MYOGRAPHY; PRIORITY JOURNAL; PULSE PRESSURE; RESISTANCE BLOOD VESSEL; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN;

EID: 0035003137     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200105000-00013     Document Type: Article

References (50)

1. 1 Folkow B, Physiological aspects of primary hypertension. Physiol Rev 1982; 62:347-504.
2. 2 Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990;70:921-971.
3. 3 Schiffrin EL. Reactivity of small blood vessels in hypertension. Relationship with structural changes. Hypertension 1992; 19(suppl II):II-1-II-9.
4. 4 Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual processes of remodelling and growth. Hypertension 1993; 21:391-397.
5. nd edn.; New York; Raven Press, 1995, ch. 31.
6. 6 Christensen KL, Mulvany MJ. Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. J Vasc Res 1993; 30:73-79.
7. 7 Folkow B. Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo haemodynamics? J Hypertens 1995; 13:1546-1559.
8. 8 Izzard AS, Heagerty AM. Hypertension and the vasculature: arterioles and the myogenic response. J Hypertens 1995; 13:1-4.
9. 9 Brush JE, Cannon RO, Schenke WH, Bonow RO, Leon MB, Maron BJ, Epstein SE. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988; 319:1302-1307.
10. 10 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of acute coronary syndromes. N Engl J Med 1992; 326:242-250, 310-318.
11. 11 Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol 1998; 32: S62-S66.
12. 12 Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000; 101:948-954.
13. 13 Schiffrin EL, Deng LY, Larochelle P. Effects of a β-blocker or a converting enzyme inhibitor on small arteries in essential hypertension. Hypertension 1994; 23:83-91.
14. 14 Deng LY, Li J-S, Schiffrin EL. Endothelium-dependent relaxation of small arteries from essential hypertensive patients. Clin Sci 1995; 88: 611-622.
15. 15 Cockroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension New Engl J Med 1994; 330:1036-1040.
16. 16 Li JS, Schiffrin EL. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1996; 28:68-74.
17. 17 Schiffrin EL Deng LY, Larochelle P. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993; 16:177-186.
18. 18 Korsgaard N, Aalkjæer C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993; 22:523-526.
19. 19 Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996; 27:1031-1038.
20. 20 Park JB, Charbonneau F, Schiffrin EL. Correlation of endothelial function in large and small arteries in human essential hypertension. J Hypertens 2001; 19:415-420.
21. 21 Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26:1235-1241.
22. 22 The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2413-2446.
23. 23 Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000; 101:1653-1659.
24. 24 Devereux RB, Alonso DR, Lutas WM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458
25. 1 receptor antagonist losartan in essential hypertension. J Renin Angiotens System 2000; 1:40-45.
26. 26 Schiffrin EL, Deng LY. Relationship of small artery structure with systolic, diastolic and pulse pressure in essential hypertension. J Hypertens 1999; 17:381-387.
27. 27 Mulvany MJ, Baumbach GL, Aalkjaer C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Letter to the editor. Hypertension 1996; 27:505-506.
28. 28 Sharifi AM, Schiffrin EL Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am J Hypertens 1998; 11:1108-1116.
29. 29 Mallion JM, Baguet JP, Siche JP, Tremel F, De Gaudemaris R. Left ventricular hypertrophy and arterial hypertrophy. Adv Exp Med Biol 1997; 432:123-133.
30. 30 Roman MJ, Pickering TG, Pini R, Schwartz JE, Devereux RB. Prevalence and determinants of cardiac and vascular hypertrophy in hypertension. Hypertension 1995; 26:369-373.
31. 31 Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Palù CD, et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998; 16:949-961.
32. 32 Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987; 61:181-186.
33. 33 Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8(suppl. 2): II-61-II-66.
34. 34 Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323:22-27.
35. 35 Tschudi MR, Mesaros S, Lüscher TF, Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Hypertension 1996; 27:32-35.
36. 36 Benzuly KH, Padgett RC, Kaul S, Plegors DJ, Armstrong ML, Heistad DD. Functional improvement precedes structural regression of atherosclerosis. Circulation 1994; 89:1810-1818.
37. 37 Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti-Rosei E. Vascular structural and functional alterations before and after the development of hypertension in SHR. Am J Hypertens 1994; 7:193-200.
38. 38 Bank AJ, Wilson RF, Kubo SH, Holte JE, Dresing TJ, Wang H. Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties. Circ Res 1995; 77:1008-1016.
39. 39 Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 1996; 27:849-853.
40. 40 Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24:471-476.
41. 41 Best PJ, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998; 128:285-288
42. 42 Gerhard M, Walsh BW, Tawakol A, Haley EA, Creager SJ, Seely EW, et al. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation 1998; 98:1158-1163.
43. 43 Koh KK, Blum A, Hathaway L, Mincemoyer R, Csako G, Waclawlw MA, et al. Vascular effects of estrogen and vitamin E therapies in postmenopausal women. Circulation 1999; 100:1851-1857.
44. 44 Thybo NK, Mulvany MJ, Jastrup B, Nielsen H, Aalkjaer C. Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension. J Hypertens 1996; 14:993-998.
45. 45 Intengan HD, Deng LY, Li JS, Schiffrin EL. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. Hypertension 1999; 33:569-574.
46. 46 Zanchi AM, Wiesel P, Aubert JF, Brunner HR, Hayoz D. Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats. Hypertension 1997; 29:1199-1203.
47. 47 Gandley RE, McLaughlin MK, Koob TJ, Little SA, McGuffee LJ. Contribution of chondroitin-dermatan sulfate-containing proteoglycans to the function of rat mesenteric arteries. Am J Physiol 1997; 273:H952-H960.
48. 48 Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension 1998; 32:560-564.
49. 49 Cooper A, Heagerty AM. Blood pressure parameters as determinants of small artery structure in human essential hypertension. Clin Sci 1997; 92:551-557.
50. 50 O'Rourke M, Frohlich ED. Pulse pressure: Is this a clinically useful risk factor? Hypertension 1999; 34:372-374.